연구동향 분석

Copeptin in Hemodialysis Patients with Left Ventricular Dysfunction

김재석 한병근 양재원 채문희 이준영 박현철 김영섭 최승옥 2015년

논문상세정보
인용/피인용
' Copeptin in Hemodialysis Patients with Left Ventricular Dysfunction' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • 의학
  • copeptin
  • hemodialysis
  • ventricular dysfunction
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
7,644 0

0.0%

' Copeptin in Hemodialysis Patients with Left Ventricular Dysfunction' 의 참고문헌

  • Vasopressin release is enhanced by the Hemocontrol biofeedback system and could contribute to better haemodynamic stability during haemodialysis
    Ettema EM Nephrol Dial Transplant 27 : 3263 ~ 3270 [2012]
  • Vasopressin release is enhanced by the Hemocontrol biofeedback system and could contribute to better haemodynamic stability during haemodialysis
    Ettema EM Nephrol Dial Transplant 27 3263-3270 [2012]
  • Response of plasma vasopressin to changes in extracellular volume and/or plasma osmolality in patients on maintenance hemodialysis
    Fasanella d’Amore T Clin Nephrol 23 : 299 ~ 302 [1985]
  • Response of plasma vasopressin to changes in extracellular volume and/or plasma osmolality in patients on maintenance hemodialysis
    Fasanella d’Amore T Clin Nephrol 23 299-302 [1985]
  • Plasma vasopressin, catecholamines and atrial natriuretic factor during hemodialysis and sequential ultrafiltration
    Os I Scand J Urol Nephrol 27 : 93 ~ 99 [1993]
  • Plasma vasopressin, catecholamines and atrial natriuretic factor during hemodialysis and sequential ultrafiltration
    Os I Scand J Urol Nephrol 27 93-99 [1993]
  • Plasma concentration of antidiuretic hormone in patients with chronic renal insufficiency on maintenance dialysis
    Horký K Horm Metab Res 11 : 241 ~ 246 [1979]
  • Plasma concentration of antidiuretic hormone in patients with chronic renal insufficiency on maintenance dialysis
    Horký K Horm Metab Res 11 241-246 [1979]
  • Osmotic and nonosmotic control of vasopressin release
    Schrier RW Am J Physiol 236 : F321 ~ F332 [1979]
  • Osmotic and nonosmotic control of vasopressin release
    Schrier RW Am J Physiol 236 F321-F332 [1979]
  • International Union of Basic and Clinical Pharmacology. LXXIV. Apelin receptor nomenclature, distribution, pharmacology, and function
    Pitkin SL Pharmacol Rev 62 : 331 ~ 342 [2010]
  • International Union of Basic and Clinical Pharmacology. LXXIV. Apelin receptor nomenclature, distribution, pharmacology, and function
    Pitkin SL Pharmacol Rev 62 331-342 [2010]
  • Increased 90-day mortality in patients with acute heart failure with elevated copeptin: secondary results from the Biomarkers in Acute Heart Failure (BACH) study
    Maisel A Circ Heart Fail 4 : 613 ~ 620 [2011]
  • Increased 90-day mortality in patients with acute heart failure with elevated copeptin: secondary results from the Biomarkers in Acute Heart Failure (BACH) study
    Maisel A Circ Heart Fail 4 613-620 [2011]
  • Endogenous and exogenous vasopressin during hemodialysis
    Thompson AM Semin Dial 22 : 472 ~ 475 [2009]
  • Endogenous and exogenous vasopressin during hemodialysis
    Thompson AM Semin Dial 22 472-475 [2009]
  • Diagnostic value of N-terminal pro-B-type natriuretic peptide (NT-proBNP) for left ventricular dysfunction in patients with chronic kidney disease stage 5 on haemodialysis
    David S Nephrol Dial Transplant 23 : 1370 ~ 1377 [2008]
  • Diagnostic value of N-terminal pro-B-type natriuretic peptide (NT-proBNP) for left ventricular dysfunction in patients with chronic kidney disease stage 5 on haemodialysis
    David S Nephrol Dial Transplant 23 1370-1377 [2008]
  • Diagnostic and prognostic impact of copeptin and high-sensitivity cardiac troponin T in patients with pre-existing coronary artery disease and suspected acute myocardial infarction
    Potocki M Heart 98 : 558 ~ 565 [2012]
  • Diagnostic and prognostic impact of copeptin and high-sensitivity cardiac troponin T in patients with pre-existing coronary artery disease and suspected acute myocardial infarction
    Potocki M Heart 98 558-565 [2012]
  • Copeptin: a new marker in cardiology
    Morawiec B J Cardiovasc Med (Hagerstown) 14 : 19 ~ 25 [2013]
  • Copeptin: a new marker in cardiology
    Morawiec B J Cardiovasc Med (Hagerstown) 14 19-25 [2013]
  • Copeptin levels associate with cardiovascular events in patients with ESRD and type 2 diabetes mellitus
    Fenske W J Am Soc Nephrol 22 : 782 ~ 790 [2011]
  • Copeptin levels associate with cardiovascular events in patients with ESRD and type 2 diabetes mellitus
    Fenske W J Am Soc Nephrol 22 782-790 [2011]
  • Complementary role of copeptin and high-sensitivity troponin in predicting outcome in patients with stable chronic heart failure
    Tentzeris I Eur J Heart Fail 13 : 726 ~ 733 [2011]
  • Complementary role of copeptin and high-sensitivity troponin in predicting outcome in patients with stable chronic heart failure
    Tentzeris I Eur J Heart Fail 13 726-733 [2011]
  • Comparison of copeptin, B-type natriuretic peptide, and amino-terminal pro-B-type natriuretic peptide in patients with chronic heart failure: prediction of death at different stages of the disease
    Neuhold S J Am Coll Cardiol 52 : 266 ~ 272 [2008]
  • Comparison of copeptin, B-type natriuretic peptide, and amino-terminal pro-B-type natriuretic peptide in patients with chronic heart failure: prediction of death at different stages of the disease
    Neuhold S J Am Coll Cardiol 52 266-272 [2008]
  • Changes in plasma levels of vasoactive peptides during standard bicarbonate hemodialysis
    Hegbrant J Nephron 63 : 303 ~ 308 [1993]
  • Changes in plasma levels of vasoactive peptides during standard bicarbonate hemodialysis
    Hegbrant J Nephron 63 303-308 [1993]
  • C-terminal provasopressin (copeptin) is associated with left ventricular dysfunction, remodeling, and clinical heart failure in survivors of myocardial infarction
    Kelly D J Card Fail 14 : 739 ~ 745 [2008]
  • C-terminal provasopressin (copeptin) is associated with left ventricular dysfunction, remodeling, and clinical heart failure in survivors of myocardial infarction
    Kelly D J Card Fail 14 739-745 [2008]
  • C-terminal provasopressin (copeptin) is a strong prognostic marker in patients with heart failure after an acute myocardial infarction: results from the OPTIMAAL study
    Voors AA Eur Heart J 30 : 1187 ~ 1194 [2009]
  • C-terminal provasopressin (copeptin) is a strong prognostic marker in patients with heart failure after an acute myocardial infarction: results from the OPTIMAAL study
    Voors AA Eur Heart J 30 1187-1194 [2009]
  • Association of copeptin and N-terminal proBNP concentrations with risk of cardiovascular death in older patients with symptoms of heart failure
    Alehagen U JAMA 305 : 2088 ~ 2095 [2011]
  • Association of copeptin and N-terminal proBNP concentrations with risk of cardiovascular death in older patients with symptoms of heart failure
    Alehagen U JAMA 305 2088-2095 [2011]
  • Assay for the measurement of copeptin, a stable peptide derived from the precursor of vasopressin
    Morgenthaler NG Clin Chem 52 : 112 ~ 119 [2006]
  • Assay for the measurement of copeptin, a stable peptide derived from the precursor of vasopressin
    Morgenthaler NG Clin Chem 52 112-119 [2006]